Attenzione! I contenuti di questa pagina sono disponibili solo nelle seguenti lingue: Inglese
Founded in the 1970s as a technology supplier to the Italian Nuclear Agency (Agenzia Nucleare Italiana), Comecer developed its early expertise in high-safety environments through collaborations with ENEA and Ansaldo, contributing to research projects and advanced prototypes.
Comecer's first production facility in 1975
Following the Italian government’s decision in 1987 to halt nuclear energy development, the company redirected its competencies toward the medical sector, transferring its know-how to the design of safety solutions for nuclear medicine applications. This transition marked the beginning of Comecer’s long-term focus on healthcare technologies.
Throughout the 1990s and early 2000s, Comecer strengthened its engineering capabilities and expanded its network of research and technology partners, establishing itself as a leading manufacturer of shielded cells and containment systems for the nuclear medicine industry.
From the mid-2000s onward, the company experienced significant international growth, driven by increasing demand for advanced containment and aseptic solutions in regulated pharmaceutical environments.
In 2011, Fondo Italiano d’Investimento, a private equity initiative backed by the Italian Ministry of Economy and Finance, acquired a minority stake in Comecer, supporting its industrial development and international expansion.
The company further expanded its technological capabilities in 2012 through the acquisition of Veenstra Instrumenten B.V. (Netherlands) and Vitrae Czech (Czech Republic), strengthening its expertise in electronic systems and software for pharmaceutical and radiopharmaceutical applications.
In 2015, Principia SGR replaced Fondo Italiano d’Investimento as a minority shareholder, continuing to support Comecer’s growth strategy and long-term development.
A major milestone was reached on March 1st, 2019, when Comecer became part of ATS Automation Tooling Systems Inc., a global leader in industrial automation. This step integrated the company into an international group and, more specifically, into the ATS Life Sciences ecosystem, reinforcing its position in highly regulated healthcare sectors.
In recent years, Comecer has continued to expand its capabilities and global presence. In 2021, the company acquired DF Siena, further strengthening its offering in specialized production equipment for the pharmaceutical sector.
In 2025, Comecer celebrates its 50th anniversary and opens a new Aseptic Filling Production Center in Barcelona, marking another step in its ongoing growth and commitment to advanced healthcare technologies.
The Comecer Group has been growing steadily since its beginnings in the early 1970′s.
Comecer is founded as a technology supplier for the Italian Nuclear Agency (ANI), establishing collaborations with ENEA and Ansaldo and developing early high-safety systems and prototypes.
Following the 1987 nuclear energy phase-out in Italy, Comecer transfers its expertise to the medical field, focusing on safety solutions for nuclear medicine laboratories.
Development and consolidation of stainless steel manufacturing technologies, becoming a core capability across Comecer’s product portfolio.
Expansion of partnerships with research and technology organizations, enabling the development of customized solutions for nuclear medicine applications.
Comecer establishes itself as a reference partner in containment and isolation technologies, supporting accuracy and safety in nuclear medicine and pharmaceutical environments.
Fondo Italiano d’Investimento acquires a minority stake, supporting industrial growth and international expansion.
Acquisition of Veenstra Instrumenten B.V. (Netherlands) and Vitrae Czech (Czech Republic), expanding capabilities in electronics and software systems.
Principia SGR becomes a minority shareholder, continuing the company’s development path.
Comecer becomes part of ATS Automation Tooling Systems Inc., entering a global industrial automation group and strengthening its position in the life sciences sector.
Acquisition of DF Siena, enhancing the offering of specialized equipment for pharmaceutical manufacturing.
Comecer celebrates its 50th anniversary and opens the Aseptic Filling Production Center in Barcelona, expanding its capabilities in aseptic processing.
Technical
Statistici
Profilazione
